Detalles de la búsqueda
1.
Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant.
J Virol
; 95(2)2020 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33115866
2.
NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses.
Proc Natl Acad Sci U S A
; 112(11): E1333-42, 2015 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25739961
3.
Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
J Virol
; 89(2): 970-88, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25355891
4.
Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.
J Virol
; 87(12): 6955-74, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23596295
5.
Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic Frontiers.
Vaccines (Basel)
; 12(2)2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400136
6.
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium.
NPJ Vaccines
; 9(1): 53, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448450
7.
New vaccinia virus promoter as a potential candidate for future vaccines.
J Gen Virol
; 94(Pt 12): 2771-2776, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24077296
8.
Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice.
J Virol
; 86(9): 5026-38, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22419805
9.
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases.
J Mol Biol
; 435(15): 168173, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301278
10.
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.
Vaccines (Basel)
; 11(2)2023 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851164
11.
Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate.
Front Immunol
; 14: 1160065, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37404819
12.
An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses.
Front Cell Infect Microbiol
; 13: 1187193, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37313341
13.
Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein.
Front Immunol
; 14: 1270908, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38045703
14.
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA).
Vaccines (Basel)
; 12(1)2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38250827
15.
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens.
J Virol
; 85(21): 11468-78, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21865377
16.
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19.
Vaccines (Basel)
; 9(3)2021 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33799505
17.
Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same Antigen.
Vaccines (Basel)
; 9(9)2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34579196
18.
Bioluminescence Imaging as a Tool for Poxvirus Biology.
Methods Mol Biol
; 2023: 269-285, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240684
19.
A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.
Viruses
; 11(2)2019 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30781504
20.
Induction of Broad and Polyfunctional HIV-1-Specific T Cell Responses by the Multiepitopic Protein TMEP-B Vectored by MVA Virus.
Vaccines (Basel)
; 7(3)2019 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31261918